Cargando…

Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach

OBJECTIVE: Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an empirical framework for patient-identified barriers to osteoporosis medication initiation and adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Haiyan, Silverman, Stuart L, Shewchuk, Richard M, Curtis, Jeffrey R, Austin, Shamly, Greenspan, Susan L, Nieves, Jeri W, Outman, Ryan C, Warriner, Amy H, Watts, Nelson B, Saag, Kenneth G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270903/
https://www.ncbi.nlm.nih.gov/pubmed/35818434
http://dx.doi.org/10.2147/RMHP.S361559
_version_ 1784744567424155648
author Qu, Haiyan
Silverman, Stuart L
Shewchuk, Richard M
Curtis, Jeffrey R
Austin, Shamly
Greenspan, Susan L
Nieves, Jeri W
Outman, Ryan C
Warriner, Amy H
Watts, Nelson B
Saag, Kenneth G
author_facet Qu, Haiyan
Silverman, Stuart L
Shewchuk, Richard M
Curtis, Jeffrey R
Austin, Shamly
Greenspan, Susan L
Nieves, Jeri W
Outman, Ryan C
Warriner, Amy H
Watts, Nelson B
Saag, Kenneth G
author_sort Qu, Haiyan
collection PubMed
description OBJECTIVE: Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an empirical framework for patient-identified barriers to osteoporosis medication initiation and adherence from physician experts. METHODS: A cognitive mapping approach involving nominal group technique (NGT) meetings and a card sorting and rating task were used to obtain formative data. We first conducted four NGT meetings with 18 women patients who were not on osteoporosis treatment to identify barriers to osteoporosis medication, then invited 27 osteoporosis physicians to sort and rate 25 patients identified barriers. Descriptive analysis, multidimensional scaling analysis, and hierarchical cluster analysis were applied for data analysis. RESULTS: A two-dimensional five-cluster cognitive map was derived to provide an organizational framework for understanding patients perceived barriers to medication initiation and adherence. The five clusters were concerns about side effects, experience of side effects, lifestyle changes, medication access and complexity, and patient uncertainty about treatment and trust in the provider. The two dimensions were interpreted as internal to patients (X-axis) and external to patients (Y-axis). CONCLUSIONS/IMPLICATIONS: Views of patients solicited in a structured format provided directions to help in designing interventions to improve osteoporosis medication initiation and adherence.
format Online
Article
Text
id pubmed-9270903
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92709032022-07-10 Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach Qu, Haiyan Silverman, Stuart L Shewchuk, Richard M Curtis, Jeffrey R Austin, Shamly Greenspan, Susan L Nieves, Jeri W Outman, Ryan C Warriner, Amy H Watts, Nelson B Saag, Kenneth G Risk Manag Healthc Policy Original Research OBJECTIVE: Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an empirical framework for patient-identified barriers to osteoporosis medication initiation and adherence from physician experts. METHODS: A cognitive mapping approach involving nominal group technique (NGT) meetings and a card sorting and rating task were used to obtain formative data. We first conducted four NGT meetings with 18 women patients who were not on osteoporosis treatment to identify barriers to osteoporosis medication, then invited 27 osteoporosis physicians to sort and rate 25 patients identified barriers. Descriptive analysis, multidimensional scaling analysis, and hierarchical cluster analysis were applied for data analysis. RESULTS: A two-dimensional five-cluster cognitive map was derived to provide an organizational framework for understanding patients perceived barriers to medication initiation and adherence. The five clusters were concerns about side effects, experience of side effects, lifestyle changes, medication access and complexity, and patient uncertainty about treatment and trust in the provider. The two dimensions were interpreted as internal to patients (X-axis) and external to patients (Y-axis). CONCLUSIONS/IMPLICATIONS: Views of patients solicited in a structured format provided directions to help in designing interventions to improve osteoporosis medication initiation and adherence. Dove 2022-07-05 /pmc/articles/PMC9270903/ /pubmed/35818434 http://dx.doi.org/10.2147/RMHP.S361559 Text en © 2022 Qu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Qu, Haiyan
Silverman, Stuart L
Shewchuk, Richard M
Curtis, Jeffrey R
Austin, Shamly
Greenspan, Susan L
Nieves, Jeri W
Outman, Ryan C
Warriner, Amy H
Watts, Nelson B
Saag, Kenneth G
Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title_full Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title_fullStr Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title_full_unstemmed Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title_short Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach
title_sort understanding physicians’ perceptions of patient-identified barriers to osteoporosis medication initiation: a cognitive mapping approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270903/
https://www.ncbi.nlm.nih.gov/pubmed/35818434
http://dx.doi.org/10.2147/RMHP.S361559
work_keys_str_mv AT quhaiyan understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT silvermanstuartl understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT shewchukrichardm understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT curtisjeffreyr understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT austinshamly understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT greenspansusanl understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT nievesjeriw understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT outmanryanc understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT warrineramyh understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT wattsnelsonb understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach
AT saagkennethg understandingphysiciansperceptionsofpatientidentifiedbarrierstoosteoporosismedicationinitiationacognitivemappingapproach